Pharmaceutical

LZ-901 by Beijing Luzhu Biotechnology for Herpes Zoster...

LZ-901 is under clinical development by Beijing Luzhu Biotechnology and currentl...

MRNA-1365 by Moderna for Human Metapneumovirus Infectio...

MRNA-1365 is under clinical development by Moderna and currently in Phase I for ...

LY-3541860 by Eli Lilly and Co for Relapsing Multiple S...

LY-3541860 is under clinical development by Eli Lilly and Co and currently in Ph...

TT-01488 by TransThera Sciences (Nanjing) for Mantle Ce...

TT-01488 is under clinical development by TransThera Sciences (Nanjing) and curr...

Influenza (quadrivalent) vaccine by Pfizer for Influenz...

Influenza (quadrivalent) vaccine is under clinical development by Pfizer and cur...

Opzelura by Incyte for Graft Versus Host Disease (GVHD)...

Opzelura is under clinical development by Incyte and currently in Phase II for G...

Influenza (quadrivalent) vaccine by Pfizer for Influenz...

Influenza (quadrivalent) vaccine is under clinical development by Pfizer and cur...

Opzelura by Incyte for Chronic Cutaneous Lupus Erythema...

Opzelura is under clinical development by Incyte and currently in Phase II for C...

SCDARIC-33 by Regeneron Pharmaceuticals for Refractory ...

SCDARIC-33 is under clinical development by Regeneron Pharmaceuticals and curren...

Bayer reports drop in Q1 sales amidst patent litigation...

Bayer announced a fall in Q1 sales and predicted future challenges in the Xarelt...

Walden Biosciences teams up with Primula for kidney dis...

Walden reported positive topline data from a Phase I clinical trial of its lead ...

AbbVie makes psychedelic play with $2bn Gilgamesh colla...

The two companies will develop neuroplastogens for psychiatric disorders as psyc...

Cytokinetics looks to take on BMS’ Camzyos in hypertrop...

Cytokinetics plans to file for approval in both the US and Europe for its hypert...

AI database to bolster research for GLP1-RAs as precisi...

Dandelion Health’s database can be used as a tool for sponsors to decide which i...

Sanofi to make €1bn biomanufacturing investment in France

Sanofi has announced a significant investment exceeding €1bn ($1.07bn) to expand...

UK Government expands opioid overdose treatment access

The UK Government is set to revise legislation, allowing professionals to supply...